Vaseem Mahboob
CIK 1655157 · Chief Financial Officer · last filed 2026-06-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.42M
Companies
3
Total Filings
23
Lifetime Open-Market Net
$297.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KMTS | Chief Financial Officer | 67,961 | $20.85 | $1.42M | $0 | 2 | 2026-06-04 |
| ENDOLOGIX INC /DE/ (ELGX) Delisted | Chief Financial Officer | 111,716 | — | — | $297.9K | 18 | 2020-03-26 |
| Insys Therapeutics, Inc. (INSY) Delisted | Director | 14,083 | — | — | $0 | 3 | 2019-04-23 |
Recent Filings · Page 3 of 3
23 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-12-15 | ENDOLOGIX INC /DE/ (ELGX) Delisted | Buy (P) | +20,000 | $125.0K | EDGAR |
| 2016-02-17 | ENDOLOGIX INC /DE/ (ELGX) Delisted | Grant (A) | +33,201 | $0 | EDGAR |
| 2015-10-16 | ENDOLOGIX INC /DE/ (ELGX) Delisted | Grant (A) | +55,310 | $0 | EDGAR |
Showing 21–23 of 23
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.